Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro) cover art

Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro)

Preserving Muscle Mass While Using GLP-1 Medications (Ozempic, Wegovy, Mounjaro)

Listen for free

View show details

About this listen

 In this episode, we address the growing clinical concern of lean-mass loss associated with GLP-1 receptor agonists such as semaglutide and tirzepatide, where studies show 20 to 45 percent of weight lost can come from muscle tissue. The discussion examines the mechanisms behind this risk and presents evidence-based strategies — including higher protein intake of 1.2 to 1.6 grams per kilogram of body weight and regular resistance training — to preserve muscle while achieving the metabolic benefits of these medications. Practical guidance is provided for patients and clinicians seeking to optimize body composition outcomes during treatment.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.